Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Post-Spinal Shivering in C-Section
NCT06318546Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in postanesthetic shivering (PAS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of Post Spinal Shivering. Started Apr 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT06318546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06318546.